Histologies of particular note included central nervous system (CNS) tumors, pancreatic tumors (all KRAS wild-type), cervical tumors and urothelial carcinomas harboring FGFR fusions or mutations. The gene discussed is KRAS; the disease is pancreatic neoplasm.